"The Center for Cancer & Blood Disorders is dedicated to providing convenient and easily accessible cancer treatment to families living in Mineral Wells and the surrounding area."

During the past decade, The Center for Cancer and Blood Disorders-Mineral Wells conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Center for Cancer and Blood Disorders-Mineral Wells" #1 collaborator was "American College of Surgeons" with 1 trials as a collaborator, "Cancer and Leukemia Group B" with 1 trials as a collaborator, "NCIC Clinical Trials Group" with 1 trials as a collaborator, "NSABP Foundation Inc" with 1 trials as a collaborator and "North Central Cancer Treatment Group" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "The Center for Cancer and Blood Disorders-Mineral Wells" are "Breast Adenocarcinoma" (1 trials), "Clear Cell Renal Cell Carcinoma" (1 trials), "Hormone Receptor Positive" (1 trials), "Recurrent Renal Cell Carcinoma" (1 trials) and "Stage IA Breast Cancer AJCC v7" (1 trials). Many other conditions were trialed in "The Center for Cancer and Blood Disorders-Mineral Wells" in a lesser frequency.

Most popular intervention types in "The Center for Cancer and Blood Disorders-Mineral Wells" are "Drug" (2 trials), "Other" (2 trials), "Biological" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (2 trials), "Anastrozole" (1 trials), "Bevacizumab" (1 trials), "Exemestane" (1 trials) and "Letrozole" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Center for Cancer and Blood Disorders-Mineral Wells" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "The Center for Cancer and Blood Disorders-Mineral Wells". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in The Center for Cancer and Blood Disorders-Mineral Wells, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in The Center for Cancer and Blood Disorders-Mineral Wells, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".